# REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

Study · id `cardio:ct-nct06399692` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06399692](<https://clinicaltrials.gov/study/NCT06399692>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06399692

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.

## Technical summary

Registry record NCT06399692. Randomized; single masking; primary purpose prevention. Start 2024-09-16 (actual); primary completion 2033-03-15 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 600 participants (planned count; ClinicalTrials.gov record NCT06399692, source copy `cardio:ctgov-nct06399692-2026-09-08`, retrieved 2026-10-26)
- Started: 2024-09-16 (actual) (ClinicalTrials.gov record NCT06399692, source copy `cardio:ctgov-nct06399692-2026-09-08`, retrieved 2026-10-26)
- Primary completion: 2033-03-15 (anticipated) (ClinicalTrials.gov record NCT06399692, source copy `cardio:ctgov-nct06399692-2026-09-08`, retrieved 2026-10-26)
- Completion: 2039-01-01 (anticipated) (ClinicalTrials.gov record NCT06399692, source copy `cardio:ctgov-nct06399692-2026-09-08`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT06399692, source copy `cardio:ctgov-nct06399692-2026-09-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06399692-2026-09-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
- Acronym: RECHARGE:W
- Condition: Coronary Artery Disease
- Intervention (Procedure): Coronary artery bypass grafting (CABG)
- Intervention (Procedure): Percutaneous coronary intervention (PCI)
- Lead sponsor: Weill Medical College of Cornell University
- Lead sponsor class: OTHER
- Collaborator: Patient-Centered Outcomes Research Institute
- Collaborator class: OTHER
- Collaborator: Icahn School of Medicine at Mount Sinai
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Weill Medical College of Cornell University (`cardio:org-weill-medical-college-of-cornell-university`)
- Registry lists this organization as a collaborator: Patient-Centered Outcomes Research Institute (`cardio:org-patient-centered-outcomes-research-institute`)
- Registry lists this organization as a collaborator: Icahn School of Medicine at Mount Sinai (`cardio:org-icahn-school-of-medicine-at-mount-sinai`)

## Provenance

Content hash: 3fa42d7122a346bf6ae6704c4c4bb7a59c22ac23f5852ccf92c34be1f19f2428
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
